Stage IVB Rectal Cancer Completed Phase 3 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0028589 (Stage IVB Rectal Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00068692Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal CancerTreatment
NCT00005036Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerTreatment